SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — David Hume Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientDavid Hume
Date of birth1711-05-07
IdentifiersMRN HR-EN012-SYN-TD; SSN (made up) 000-12-3049
Document date2026-11-01
AuthorFiona Gallacher, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care visit for three months of looser stools with dark blood, tiredness, and weight loss. Concerns: Three months of looser, more frequent stools with dark blood mixed in on several days, tiredness, and about 6 kg of unintended weight loss; Wants plain information about what is wrong and wants to keep working on his books through treatment. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ferric carboxymaltose 750 mg intravenous infusion, two doses one week apart750 mg IV once a week for two dosesIntravenous route1775-06-01 to 1775-06-08completedS
Capecitabine 500 mg oral tablet, four tablets (1749 mg, 1000 mg/m²) by mouth twice daily on days 1 to 14 of each 21-day cycle, four cyclesFour tablets twice daily on days 1 to 14 of each 21-day cycleOral route1775-07-20 to 1775-10-04completedS
Oxaliplatin 130 mg/m² (260 mg) intravenous infusion on day 1 of each 21-day cycle, four cycles260 mg IV on day 1 every 21 daysIntravenous route1775-07-20 to 1775-09-21completedS
Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea during chemotherapyOne tablet every 8 hours as needed for nauseaOral route1775-07-20 to 1775-10-04completedS
Loperamide 2 mg oral capsule, two capsules after the first loose stool, then one after each loose stool, no more than eight a dayAs needed for diarrhea on capecitabineOral route1775-07-20 to 1775-10-04completedS

Procedures

ProcedureDatesStatusEvidence
Colonoscopy to the cecum with biopsy: 4 cm ulcerated, partly circumferential, non-obstructing mass at 28 cm in the sigmoid colon, tattooed; no other lesions. Biopsy: moderately differentiated adenocarcinoma, mismatch-repair proteins (MLH1, PMS2, MSH2, MSH6) intact1775-05-19 to 1775-05-19completedS
CT of the chest, abdomen, and pelvis with contrast: sigmoid wall thickening with two pericolic lymph nodes up to 7 mm; lungs clear; one 9 mm indeterminate low-density lesion in liver segment VI1775-05-21 to 1775-05-21completedS
MRI of the liver with contrast: the 9 mm segment VI lesion is a typical hemangioma, with peripheral nodular enhancement and progressive fill-in; no liver metastases1775-06-04 to 1775-06-04completedS
Laparoscopic sigmoid colectomy with primary anastomosis and no stoma. Pathology: adenocarcinoma, moderately differentiated, pT3 N1a (1 of 22 nodes), margins clear, no lymphovascular or perineural invasion; stage IIIB1775-06-16 to 1775-06-16completedS
Adjuvant CAPOX chemotherapy, four 21-day cycles (three months), given by medical oncology1775-07-20 to 1775-10-04completedS

Immunizations

DateVaccineStatusEvidence
1774-10-14Influenza vaccine, 1774-1775 seasoncompletedS
1768-03-12Tdap vaccinecompletedS
1775-10-28Influenza vaccine, 1775-1776 seasoncompletedS
1775-10-28Pneumococcal conjugate vaccine PCV20completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
September 1729Illness from about the age of eighteen, given the contemporary label 'the disease of the learned', with scurvy spots on the fingers, a watery mouth, and later a ravenous appetite and palpitations; treated with bitters, anti-hysteric pills, claret, and daily ridingD (CLM-0003)

Family History

RelativeConditionAge at deathEvidence
fatherDied when Hume was an infant; cause not recorded in the cited sourceD (CLM-0002)
motherDied before 1749; a physician's letter of early 1776 reports Hume's statement that she had the same constitution and died of the same bowel disorder, which the source does not describe furtherD (CLM-0002, CLM-0005)

Health Concerns

ConcernStatusEvidence
Three months of looser, more frequent stools with dark blood mixed in on several days, tiredness, and about 6 kg of unintended weight lossactiveS
Wants plain information about what is wrong and wants to keep working on his books through treatmentactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 12.1 on 1775-09-08; MCV [Entitic mean volume] in Red Blood Cells by Automated count 89 on 1775-10-19; Leukocytes [#/volume] in Blood by Automated count 4.6 on 1775-09-08; Platelets [#/volume] in Blood by Automated count 156 on 1775-09-08; Ferritin [Mass/volume] in Serum or Plasma 186 on 1775-07-13; Iron saturation [Mass Fraction] in Serum or Plasma 24 on 1775-07-13; Sodium [Moles/volume] in Serum or Plasma 139 on 1775-05-11; Potassium [Moles/volume] in Serum or Plasma 4.2 on 1775-05-11; Creatinine [Mass/volume] in Serum or Plasma 0.92 on 1775-10-19; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1770)/1.73 sq M 93 on 1775-10-19; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 on 1775-10-19; Albumin [Mass/volume] in Serum or Plasma 3.9 on 1775-07-13; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1775-10-28; Carcinoembryonic Ag [Mass/volume] in Serum or Plasma 1.8 on 1775-10-19; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 on 1775-06-01; Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 88 on 1775-06-01; Bilirubin.total [Mass/volume] in Serum or Plasma 0.7 on 1775-10-19; Neutrophils [#/volume] in Blood by Automated count 2.4 on 1775-09-08; Cholesterol [Mass/volume] in Serum or Plasma 196 on 1775-10-28; Cholesterol in HDL [Mass/volume] in Serum or Plasma 52 on 1775-10-28; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 118 on 1775-10-28; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 1775-10-28; Total score [AUDIT-C] 4 on 1775-10-28 [S]

Strengths and supports: Supports: a wide circle of friends who come to supper each week, and family nearby [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Adenocarcinoma of the sigmoid colon, suspected at presentation and confirmed by colonoscopic biopsy; synthetic modern diagnosis linked to the documented 1775 bowel disorder and its retrospective interpretation as colon canceractiveconfirmed C18.7S — Synthetic diagnosis confirmed by biopsy and resection in the modern episode; the historical diagnosis remains a retrospective interpretation (R).
Iron deficiency anemia from chronic blood loss from the colon tumoractiveconfirmed D50.0S — Synthetic finding echoing the documented 'hemorrhage in the upper part of the intestines'; no blood count from his lifetime exists.
Hemangioma of the liver, 9 mm, segment VI; incidental finding characterized by MRI, not a metastasisactiveconfirmed D18.03S — Synthetic incidental finding; it addresses, and does not confirm, the unverified suggestion of liver spread.
Acute viral upper respiratory infection during adjuvant chemotherapy, without fever or neutropenia; resolvedresolvedconfirmed J06.9S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.
Oxaliplatin-induced sensory peripheral neuropathy, grade 1, fingertips and toe tips, without functional impairmentactiveconfirmed G62.0S — Synthetic expected toxicity of adjuvant oxaliplatin.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1775-05-11Hemoglobin [Mass/volume] in Blood10.6g/dL13.2-16.6 g/dLLowS
1775-05-11MCV [Entitic mean volume] in Red Blood Cells by Automated count74fL80-100 fLLowS
1775-05-11Leukocytes [#/volume] in Blood by Automated count7.410*3/uL4-11 10*3/uLNormalS
1775-05-11Platelets [#/volume] in Blood by Automated count43810*3/uL150-400 10*3/uLHighS
1775-05-11Ferritin [Mass/volume] in Serum or Plasma9ng/mL30-400 ng/mLLowS
1775-05-11Iron saturation [Mass Fraction] in Serum or Plasma6%20-50%LowS
1775-05-11Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1775-05-11Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
1775-05-11Creatinine [Mass/volume] in Serum or Plasma0.94mg/dL0.74-1.35 mg/dLNormalS
1775-05-11Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1770)/1.73 sq M91mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1775-05-11Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-55 U/LNormalS
1775-05-11Albumin [Mass/volume] in Serum or Plasma3.8g/dL3.5-5 g/dLNormalS
1775-05-11Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
1775-06-01Carcinoembryonic Ag [Mass/volume] in Serum or Plasma6.4ng/mL<=3 ng/mLHighS
1775-06-01Hemoglobin [Mass/volume] in Blood10.3g/dL13.2-16.6 g/dLLowS
1775-06-01Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-55 U/LNormalS
1775-06-01Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L8-48 U/LNormalS
1775-06-01Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma88U/L40-129 U/LNormalS
1775-06-01Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
1775-07-13Carcinoembryonic Ag [Mass/volume] in Serum or Plasma2.2ng/mL<=3 ng/mLNormalS
1775-07-13Hemoglobin [Mass/volume] in Blood12.4g/dL13.2-16.6 g/dLLowS
1775-07-13MCV [Entitic mean volume] in Red Blood Cells by Automated count82fL80-100 fLNormalS
1775-07-13Leukocytes [#/volume] in Blood by Automated count6.810*3/uL4-11 10*3/uLNormalS
1775-07-13Neutrophils [#/volume] in Blood by Automated count4.110*3/uL1.5-7.7 10*3/uLNormalS
1775-07-13Platelets [#/volume] in Blood by Automated count31210*3/uL150-400 10*3/uLNormalS
1775-07-13Ferritin [Mass/volume] in Serum or Plasma186ng/mL30-400 ng/mLNormalS
1775-07-13Iron saturation [Mass Fraction] in Serum or Plasma24%20-50%NormalS
1775-07-13Creatinine [Mass/volume] in Serum or Plasma0.96mg/dL0.74-1.35 mg/dLNormalS
1775-07-13Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1770)/1.73 sq M88mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1775-07-13Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma20U/L7-55 U/LNormalS
1775-07-13Bilirubin.total [Mass/volume] in Serum or Plasma0.5mg/dL0.1-1.2 mg/dLNormalS
1775-07-13Albumin [Mass/volume] in Serum or Plasma3.9g/dL3.5-5 g/dLNormalS
1775-07-13Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
1775-10-19Carcinoembryonic Ag [Mass/volume] in Serum or Plasma1.8ng/mL<=3 ng/mLNormalS
1775-10-19Hemoglobin [Mass/volume] in Blood12.8g/dL13.2-16.6 g/dLLowS
1775-10-19MCV [Entitic mean volume] in Red Blood Cells by Automated count89fL80-100 fLNormalS
1775-10-19Leukocytes [#/volume] in Blood by Automated count5.210*3/uL4-11 10*3/uLNormalS
1775-10-19Neutrophils [#/volume] in Blood by Automated count2.910*3/uL1.5-7.7 10*3/uLNormalS
1775-10-19Platelets [#/volume] in Blood by Automated count12810*3/uL150-400 10*3/uLLowS
1775-10-19Creatinine [Mass/volume] in Serum or Plasma0.92mg/dL0.74-1.35 mg/dLNormalS
1775-10-19Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1770)/1.73 sq M93mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1775-10-19Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma31U/L7-55 U/LNormalS
1775-10-19Bilirubin.total [Mass/volume] in Serum or Plasma0.7mg/dL0.1-1.2 mg/dLNormalS
1775-10-19Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1775-09-08Leukocytes [#/volume] in Blood by Automated count4.610*3/uL4-11 10*3/uLNormalS
1775-09-08Neutrophils [#/volume] in Blood by Automated count2.410*3/uL1.5-7.7 10*3/uLNormalS
1775-09-08Hemoglobin [Mass/volume] in Blood12.1g/dL13.2-16.6 g/dLLowS
1775-09-08Platelets [#/volume] in Blood by Automated count15610*3/uL150-400 10*3/uLNormalS
1775-10-28Cholesterol [Mass/volume] in Serum or Plasma196mg/dL<=199 mg/dLNormalS
1775-10-28Cholesterol in HDL [Mass/volume] in Serum or Plasma52mg/dL>=40 mg/dLNormalS
1775-10-28Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation118mg/dL<=99 mg/dLHighS
1775-10-28Hemoglobin A1c/Hemoglobin.total in Blood5.5%<=5.6%NormalS
1775-10-28Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1775-10-28Total score [AUDIT-C]4{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1775-05-11Body height178cmS
1775-05-11Body weight88kgS
1775-05-11Body mass index (BMI) [Ratio]27.8kg/m2S
1775-05-11Systolic blood pressure132mm[Hg]S
1775-05-11Diastolic blood pressure80mm[Hg]S
1775-05-11Heart rate92/minS
1775-05-11Respiratory rate16/minS
1775-05-11Body temperature36.8CelS
1775-05-11Oxygen saturation in Arterial blood by Pulse oximetry98%S
1775-06-01Body height178cmS
1775-06-01Body weight87.2kgS
1775-06-01Body mass index (BMI) [Ratio]27.5kg/m2S
1775-06-01Systolic blood pressure130mm[Hg]S
1775-06-01Diastolic blood pressure78mm[Hg]S
1775-06-01Heart rate88/minS
1775-06-01Respiratory rate16/minS
1775-06-01Body temperature36.7CelS
1775-06-01Oxygen saturation in Arterial blood by Pulse oximetry98%S
1775-07-13Body height178cmS
1775-07-13Body weight82.5kgS
1775-07-13Body mass index (BMI) [Ratio]26kg/m2S
1775-07-13Systolic blood pressure124mm[Hg]S
1775-07-13Diastolic blood pressure76mm[Hg]S
1775-07-13Heart rate78/minS
1775-07-13Respiratory rate16/minS
1775-07-13Body temperature36.6CelS
1775-07-13Oxygen saturation in Arterial blood by Pulse oximetry98%S
1775-10-19Body height178cmS
1775-10-19Body weight81kgS
1775-10-19Body mass index (BMI) [Ratio]25.6kg/m2S
1775-10-19Systolic blood pressure122mm[Hg]S
1775-10-19Diastolic blood pressure74mm[Hg]S
1775-10-19Heart rate76/minS
1775-10-19Respiratory rate14/minS
1775-10-19Body temperature36.6CelS
1775-10-19Oxygen saturation in Arterial blood by Pulse oximetry99%S
1775-09-08Body height178cmS
1775-09-08Body weight81.6kgS
1775-09-08Body mass index (BMI) [Ratio]25.8kg/m2S
1775-09-08Systolic blood pressure118mm[Hg]S
1775-09-08Diastolic blood pressure72mm[Hg]S
1775-09-08Heart rate84/minS
1775-09-08Respiratory rate16/minS
1775-09-08Body temperature37.3CelS
1775-09-08Oxygen saturation in Arterial blood by Pulse oximetry97%S
1775-10-28Body height178cmS
1775-10-28Body weight81.4kgS
1775-10-28Body mass index (BMI) [Ratio]25.7kg/m2S
1775-10-28Systolic blood pressure122mm[Hg]S
1775-10-28Diastolic blood pressure74mm[Hg]S
1775-10-28Heart rate72/minS
1775-10-28Respiratory rate14/minS
1775-10-28Body temperature36.6CelS
1775-10-28Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
1775-05-11Primary care visit for three months of looser stools with dark blood, tiredness, and weight lossfinishedS
1775-06-01Review of colonoscopy, biopsy, and staging CT; intravenous iron; medical oncology consultationfinishedS
1775-07-13Review four weeks after laparoscopic sigmoid colectomy, before adjuvant chemotherapyfinishedS
1775-10-19Review two weeks after completing adjuvant CAPOX and start of survivorship surveillancefinishedS
1775-09-08Same-day sick visit for a head cold and cough during chemotherapyfinishedS
1775-10-28Adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Colonoscopy with biopsy, CT of the chest, abdomen, and pelvis, and baseline CEA for iron deficiency anemia with rectal bleeding in a man of 64completedGL-AGA-IDA-2020, GL-NCCN-COLON-2025, GL-CMID-2026S
Medical oncology consultation to review staging, the indeterminate liver lesion, the order of treatment, and adjuvant therapycompletedGL-NCCN-COLON-2025S
Intravenous ferric carboxymaltose before surgery to correct iron deficiency anemia, with ferritin and blood count rechecked six to eight weeks latercompletedGL-AGA-IDA-2020, GL-CMID-2026S
Laparoscopic sigmoid colectomy with lymph node dissection by the colorectal surgery teamcompletedGL-NCCN-COLON-2025S
Three months (four cycles) of adjuvant CAPOX for low-risk stage III disease, after DPYD genotyping, with neuropathy, blood count, and diarrhea checks at every visitcompletedGL-IDEA-2018, GL-NCCN-COLON-2025, GL-CMID-2026S
Survivorship surveillance: history, examination, and CEA every 3 to 6 months for 2 years, then every 6 months to 5 years; CT of the chest, abdomen, and pelvis every 6 to 12 months for 5 years; colonoscopy one year after resectioncompletedGL-CMID-2026, GL-ASCRS-2021, GL-ACS-CRC-2015S
Distress and depression screening at each visit, at least 150 minutes of activity a week, alcohol at or below one drink a day, and a written survivorship care plancompletedGL-ACS-CRC-2015, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Complete diagnosis, staging, and curative resection within six weeks of presentation1775-07-13completedColonoscopy in eight days, staging complete in three and a half weeks, colectomy at five weeksS
Replete iron stores before surgery and recover hemoglobin by the postoperative review1775-07-13completedFerritin 186 ng/mL and hemoglobin 12.4 g/dL four weeks after surgery, up from 9 ng/mL and 10.6 g/dLS
Complete three months of adjuvant CAPOX with neuropathy no worse than grade 11775-10-19completedFour cycles completed on schedule; grade 1 sensory neuropathyS
Start survivorship surveillance with a written survivorship care plan1775-10-19completedSurvivorship care plan given; CEA 1.8 ng/mL; CT and colonoscopy dates setS

Functional Status

Mental Status